Abbott Laboratories (NYSE:ABT)
| 124.67 Delayed Data As of 4:00pm ET |  +0.32 / +0.26%Today’s Change | 86.16 Today|||52-Week Range 128.54 | +13.86% Year-to-Date |
ABT Regular Dividend: ABT began trading ex-dividend on 04/14/21. A $0.45 dividend will be paid to shareholders of record as of 04/15/21.
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 124.35 |
| Today’s open | 123.87 |
| Day’s range | 123.73 - 125.40 |
| Volume | 6,844,725 |
| Average volume (3 months) | 5,052,255 |
| Market cap | $220.3B |
Data as of 4:00pm ET, 04/19/2021
Growth & Valuation
| Earnings growth (last year) | +21.67% |
| Earnings growth (this year) | +38.55% |
| Earnings growth (next 5 years) | +15.74% |
| Revenue growth (last year) | +8.48% |
| P/E ratio | 50.0 |
| Price/Sales | 5.65 |
| Price/Book | 6.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -1.81 | -0.69% |
| BSXBoston Scientific Co... | -0.03 | -0.07% |
| BAXBaxter International... | -0.06 | -0.07% |
| DXCMDexcom Inc | -7.16 | -1.79% |
Data as of 4:00pm ET, 04/19/2021
Financials
| Next reporting date | April 20, 2021 |
| EPS forecast (this quarter) | $1.27 |
| Annual revenue (last year) | $34.6B |
| Annual profit (last year) | $4.5B |
| Net profit margin | 12.86% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
